Open Access System for Information Sharing

Browse by Researchers

SUNG, YOUNG CHUL (성영철)

Div of Integrative Biosci & Biotech(융합생명공학부)

Field(s)

Show more items...

H-INDEX

Chart.

Keyword

INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAGS:1||HTLVIII:1||HP4:1||CELLULAR UPTAKE:1||CANCER VACCINES:1||T cell response:1||HEPATITISCVIRUS:1||STIMULATION:1||HUMANLYMPHOCYTES:1||Treg:1||SUPPRESSOR COMMITMENT:1||SPINDLE CHECKPOINT:1||COMPLEXES:1||ANTIHIV RESPONSE:1||INVIVO ELECTROPORATION:1||PAPILLOMAVIRUS TYPE16 E7:1||MHCCLASSI:1||PROTEIN EXPRESSION:1||A VIRUS:1||FUSION PROTEIN:1||ADULTS:1||CISPLATIN:1||rheumatoid arthritis:1||CHEMOKINE RECEPTORS:1||COLLAGENINDUCED ARTHRITIS:1||ANTAGONISTS:1||Erectile dysfunction:1||NGlycan:1||MURINE MODEL:1||CYTOKINE PRODUCTION:1||experimental autoimmune encephalomyelitis:1||APOPTOTIC CELLS:1||T(H)1:1||immune modulation:1||PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES:1||CLONAL EXPANSION:1||SISTERCHROMATID COHESION:1||CD8(+) TCELLS:1||INDUCED CELLDEATH:1||CYCLINA:1||IL12N220L:1||INTRACELLULAR BACTERIA:1||LIVERCELL:1||MAP KINASE:1||MAJOR HISTOCOMPATIBILITY COMPLEX:1||TAP:1||LUNGCANCER CELLS:1||BREASTCANCER:1||Rb pathway:1||C VIRUS CORE:1||ACTIVATION DOMAIN:1||NMRSPECTROSCOPY:1||HEMATOPOIETICCELLS:1||REGION:1||SYNOVIAL FIBROBLASTS:1||LIGAND TRAIL:1||INTERFERONGAMMA PRODUCTION:1||NS3 gene:1||bicistronic plasmid:1||PLASMIDS:1||envelope proteins:1||HYPERVARIABLE REGION1:1||CPG MOTIFS:1||SEQUENCE SIMILARITY:1||PROGENITOR CELLS:1||protein transduction domains:1||MEDIATED GENETRANSFER:1||COLONCARCINOMA:1||NFKAPPAB:1||INTERLEUKIN12 P40:1||MEDIATED SIGNALTRANSDUCTION:1||LAMIVUDINE THERAPY:1||hepatitis B virus:1||LYMPHOCYTE RESPONSIVENESS:1||LAMIVUDINE:1||mitotic cell cycle:1||LIVER BIOPSIES:1||VACCINIA VIRUS:1||Lytic and nonlytic Fc fusion:1||in vitro replication:1||Cervical cancer:1||CD40L:1||TUMORANTIGEN:1||TIANTAN VACCINIA:1||CELL RESPONSES:1||MATRIX PROTEIN2:1||regulatory T cells:1||PATHOGENIC TCELL:1||Fibrosis:1||Interferongammainducible protein 10:1||ACCUMULATION:1||human adipose tissuederived mesenchymal stromal cells (hADMSCs):1||GROWTHFACTORBETA:1||CHOCELLS:1||CANCERCELLS:1||SUBUNIT VACCINE:1||INTRATUMORAL INJECTION:1||COEXPRESSION:1||KILLERCELLS:1||CD4(+) T cells:1||CD8(+) T cells:1||HA:1||CLASSII TRANSACTIVATOR:1||MARROWDERIVED CELLS:1||IMMUNOSTIMULATORY DNASEQUENCES:1||CD8 TCELLS:1||NAIVE:1||PROTEIN PHOSPHATASE 2A:1||PREMATURE ANAPHASE:1||MEMORY:1||DISEASE:1||PERSIST:1||MAINTENANCE:1||LYMPHOCYTE RESPONSES:1||ASK1:1||HEAVYCHAINS:1||KILLERCELL:1||PLAY:1||ACTIVATED PROTEINKINASES:1||antioxidant:1||ATOMICSTRUCTURE:1||EPITOPE:1||BACTERIOPHAGE:1||MOUSE SKELETALMUSCLE:1||ENCEPHALOMYOCARDITIS VIRUS:1||CELLCYCLE CONTROL:1||RECEPTOR PROTEIN:1||CHEMICALSHIFT:1||INTERFERON:1||EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS:1||human papilloma virus:1||MOLECULARCLONING:1||SERINEPROTEASE:1||NONSTRUCTURAL PROTEIN3:1||PREDOMINANT GENOTYPE:1||CTL RESPONSES:1||longterm protection:1||POTENT:1||neuron:1||COLI BETAGALACTOSIDASE:1||ADENOASSOCIATED VIRUS:1||interference:1||INVIVO:1||EXPRESSED PROTEIN:1||ENVELOPE GLYCOPROTEINS:1||PURIFICATION:1||OLIGOMERIZATION:1||SINDBISVIRUS:1||MESSENGERRNAS:1||NONSTRUCTURAL PROTEINS:1||HCV RNA:1||PROTOONCOGENE:1||THYMOCYTES:1||HUMAN BRAIN:1||INDUCE:1||INSTRUCTION:1||negative selection:1||HUMAN EPITHELIALCELLS:1||ALLERGIC INFLAMMATION:1||C VIRUS:1||STRUCTURAL PROTEINS:1||ENVELOPE PROTEIN:1||PstS3:1||Broad immunity:1||Mucosal immunization:1||VECTOR VACCINE:1||Prolonged survival:1||SETPOINT:1||Primeboost:1||SUICIDE GENE:1||INDUCIBLE PROTEIN10:1||tumor necrosis factor (TNF)related apoptosisinducing ligand (TRAIL):1||Mesenchymal stem cell:1||GLIOBLASTOMA CELLS:1||LIQUIDCHROMATOGRAPHY:1||MASS:1||GLYCOSYLATION:1||therapeutic model:1||injection route:1||BCELLS:1||Suppression:1||CD8(+):1||EPIDERMAL LANGERHANS CELLS:1||3 &apos:1||phosphodiester:1||PD1:1||Mycobacterium tuberculosis:1||ANAPHASE:1||G(1) ARREST:1||RAS:1||core:1||MOLECULES:1||TRANSPORT:1||RADICALS:1||ACCELERATION:1||STIMULATORY FACTOR NKSF:1||INVIVO TRANSFECTION:1||mouse double minute 2:1||PROTEIN SECONDARY STRUCTURE:1||THELPER CELLS:1||recombinant:1||INFLAMMATORY DEMYELINATION:1||peptide:1||vaginal adjuvant:1||DIRECTINJECTION:1||B SURFACEANTIGEN:1||CHALLENGE:1||EGFP:1||SEAP:1||coinfection:1||RISK:1||DNA vaccination:1||EMCV:1||MOUSE MUSCLE:1||DIRECT GENETRANSFER:1||SERINE PROTEINASE:1||E2 protein:1||PROGRAMMED CELL DEATH (APOPTOSIS):1||GENES:1||PEPTIDES:1||INTRACELLULAR PROTEIN DELIVERY:1||3RD HELIX:1||IL23:1||INVOLVEMENT:1||BETA:1||SIGNAL TRANSDUCER:1||in vivo kinetics:1||NS5A:1||INFECTED RHESUSMONKEYS:1||OPTIMAL INDUCTION:1||INTERLEUKIN7:1||correlate of protection:1||MONKEYS:1||Human papillomavirus:1||Macaque:1||DNA VACCINE:1||RHESUSMONKEYS:1||GLIOMA:1||INVIVO:21||INFECTION:17||MICE:14||IMMUNERESPONSES:12||PLASMID DNA:11||DENDRITIC CELLS:10||hepatitis C virus:9||DNA vaccine:9||PROTEIN:8||EXPRESSION:8||INTERLEUKIN12:8||ACTIVATION:7||DNA:7||GENETHERAPY:7||TCELLS:7||APOPTOSIS:6||RESPONSES:6||IL12:6||GENOME:6||IMMUNIZATION:6||ANTIBODIES:6||CELLS:6||INTERFERONGAMMA:6||NONA:6||VACCINATION:5||HEPATOCELLULARCARCINOMA:5||RHEUMATOIDARTHRITIS:5||SURVIVAL:5||NONBHEPATITIS:5||BINDING:5||TCELL RESPONSES:5||MURINE:5||MAMMALIANCELLS:5||IMMUNITY:5||VACCINES:5||BACTERIALDNA:4||ANTIGEN:4||VIRUS:4||VP16:4||SEQUENCE:4||AIDS:4||HCV:4||TUMORNECROSISFACTOR:4||TRANSGENIC MICE:4||TLYMPHOCYTE RESPONSES:4||GENEEXPRESSION:4||RECEPTOR:4||IMMUNOGENICITY:4||INDUCTION:4||FACTORALPHA:3||NEUTRALIZING ANTIBODIES:3||Vaccine:3||HUMAN CANCERS:3||INJECTION:3||IMMUNERESPONSE:3||SIV:3||SIMIAN IMMUNODEFICIENCY VIRUS:3||DISEASE PROGRESSION:3||VACCINE:3||HIV1:3||ADENOVIRUS:3||THERAPY:3||SUPPRESSION:3||ANTIGENPRESENTING CELLS:3||CUTTING EDGE:3||MECHANISM:3||hepatocellular carcinoma:3||P40 HOMODIMER:3||CANCERTHERAPY:3||PROTECTIVE IMMUNITY:3||BLOOD MONONUCLEARCELLS:3||SENSITIVITY:3||ELEMENTS:3||HYDROPHOBIC AMINOACIDS:3||NS3:3||RNA:3||PHARMACOKINETICS:3||TRANSACTIVATION DOMAIN:3||RHESUS MACAQUES:3||Adenovirus:3||STIMULATORY FACTOR:3||LONG TERMINAL REPEAT:3||LYMPHOCYTES:3||GENE:3||DEATH:3||SPINDLE ASSEMBLY CHECKPOINT:3||CONSTRUCTION:3||CANCER:3||ARABIDOPSISTHALIANA:2||RESPIRATORYTRACT:2||CENTRAL VACUOLE:2||metastasis:2||FLEXIBILITY:2||STIMULATING PROTEIN NESP:2||ADAPTIVE IMMUNITY:2||apoptosis:2||MITOSIS:2||chemotherapy:2||plasmid DNA vaccine:2||LIVER:2||HETERONUCLEAR NMRSPECTROSCOPY:2||GENETIC DRIFT:2||LYMPHOID ORGANS:2||ENHANCEMENT:2||DNA immunization:2||CORE PROTEIN:2||HBV:2||IMMUNOTHERAPY:2||HIV:2||REPLICATION:2||RECENT PROGRESS:2||APOPTOSISINDUCING LIGAND:2||MYCOBACTERIUMTUBERCULOSIS:2||PROTECTIVE EFFICACY:2||RECOMBINANTHUMANERYTHROPOIETIN:2||BINDINGSITE:2||Influenza:2||DIFFERENTIATION:2||EOSINOPHILIA:2||CYTOKINE:2||TYROSINE PHOSPHORYLATION:2||p53:2||CELL STIMULATORY FACTOR:2||CENTRALNERVOUSSYSTEM:2||INVITRO:2||COACTIVATORS:2||VIRUSINFECTION:2||EFFICACY:2||PHARMACODYNAMICS:2||PHASEI:2||PROMOTER:2||KINETOCHORE LOCALIZATION:2||PROTEINKINASE:2||RAT EMBRYO FIBROBLASTS:2||RESONANCE:2||WKYMVm:2||PHOSPHOINOSITIDE HYDROLYSIS:2||RECOMBINANT INTERLEUKIN2:2||MONOCLONALANTIBODY:2||DOMAIN:2||immune response:2||INSECT CELLS:2||HEPATITISC VIRUS:2||mucosal immunity:2||CHALLENGE INFECTION:2||CHOLERATOXIN:2||DESTRUCTIVE ARTHRITIS:2||INFLAMMATION:2||TNFalpha:2||TNF blocker:2||DELIVERY:2||BCG:2||CD4(+):2||biodistribution:2||IMMUNOSTIMULATORY DNA:2||FAMILY:2||NS3/4A:2||HUMAN DENDRITIC CELLS:2||SUPEROXIDE GENERATION:2||KAPPAB:2||LYMPHOCYTE MATURATION FACTOR:2||cytokine:2||WILDTYPE:2||ASSOCIATION:2||NATURALKILLERCELLS:2||ERtargeted haemagglutinin:2||Electroporation:2||MHC CLASSI:2||protease:2||VALDMET:2||SELECTIVE STIMULATION:2||TUMOR:2||EXPRESSION VECTOR:2||LESS PROMOTER:2||HOMEOSTASIS:2||adjuvant Saponin:2||highly pathogenic avian influenza virus:2||plant edible vaccine:2||TNFRhyFc:2||BIOLOGICALACTIVITY:2||HEMAGGLUTININ:2||PROTEINS:2||TCELL HOMEOSTASIS:2||MUCOSAL IMMUNERESPONSES:2||VACCINATION STRATEGIES:2||IRELATED RECEPTOR:2||HUMANIGG:2||ANTIGEN PRESENTATION:2||MOTIFS:2||Ag85A:2||IL12 PRODUCTION:2||hepatocarcinogenesis:2||LIBRARY:2||DVARIANT:2||ALPHAHELIX:2||CLEAVAGE:2||SKELETALMUSCLE:2||TFIID COMPLEX:2||DNA IMMUNIZATION:2||TRANSGOLGI NETWORK:2||IFNGAMMA:2||STEMCELLS:2||Hybrid Fc:2||COLONYSTIMULATING FACTOR:2||core protein:2||CD80:2||GENETIC IMMUNIZATION:2||DEFICIENT MICE:2||TSLP:2||influenza infection:2||DSSinduced colitis:1||SODIUMINDUCED COLITIS:1||Chronic hepatitis C:1||GLIOMA THERAPY:1||URETHRAL SPHINCTER:1||SIDEPOPULATION:1||Fcfusion protein:1||COMPLEMENT:1||interleukin12:1||NKT CELLS:1||Costimulation:1||Fusion:1||EXTRACELLULAR DOMAIN:1||A VACCINE:1||ADJUVANT:1||asthma:1||dG(6)run:1||vaccination:1||ANAPHASEPROMOTING COMPLEX:1||HUMAN LUNG CANCERS:1||Th1CD4(+) Tcell response:1||ACTIVE PULMONARY TUBERCULOSIS:1||AVIUM INFECTION:1||GX12:1||P53INDEPENDENT PATHWAY:1||SERINE PHOSPHORYLATION:1||ICE/CED3 FAMILY PROTEASES:1||WAF1/CIP1:1||G(1):1||G(1)CYCLINS:1||ENVELOPE GLYCOPROTEIN:1||protection:1||FACTOR GENE:1||nuclear magnetic resonance:1||unstructured:1||IFNGAMMA PRODUCTION:1||MURINE TUMORS:1||IMMUNOREGULATORY FUNCTIONS:1||COMPLETE CODING SEQUENCE:1||mutagenesis:1||POTYVIRUS:1||DNA VACCINATION:1||ANTIBODY:1||DNA inoculation:1||glia:1||Sindbis virus:1||NONAHEPATITIS:1||GMCSF:1||PROTECTION:1||DELTA ANTIGEN:1||VIRALRNA:1||diagnosis:1||renal failure:1||BLOODDONORS:1||TRANSACTIVATOR GENE:1||recombinant adenovirus:1||ANTENNAPEDIA HOMEODOMAIN:1||TRANSDUCTION DOMAINS:1||MEMBRANE:1||adenovirus:1||DIFFERENTIAL REGULATION:1||BONE DESTRUCTION:1||EROSION:1||INTERLEUKIN17:1||HETERODIMERIC CYTOKINE:1||DCs:1||TCR:1||DNAMEDIATED IMMUNIZATION:1||OXIDATIVE STRESS:1||RECEPTORS:1||E6:1||SAFETY:1||HSVTK:1||TRAIL:1||interleukin17producing T cells:1||TGFBETA:1||AUTOIMMUNE ENCEPHALOMYELITIS:1||IL12p40:1||SEVERE CROHNSDISEASE:1||BOWELDISEASE:1||MESSENGERRNA:1||Fc fusion protein:1||ANTITUMORACTIVITY:1||EFFICIENT PROTECTION:1||mesenchymal stem cell:1||FAS LIGAND:1||EFFICIENT PRESENTATION:1||AIRWAY HYPERRESPONSIVENESS:1||3RD SIGNAL:1||MAD2:1||CELLULARIMMUNITY:1||SELFANTIGENS:1||RECOMBINANT ADENOVIRUSES:1||Fas:1||Th1/Th2:1||EMCV VP1:1||SURFACEANTIGEN:1||NUCLEARMAGNETICRESONANCE:1||PEPTIDEFRAGMENTS:1||KINASE:1||TH1 CELLS:1||Flagellin:1||TNF RECEPTOR SUPERFAMILY:1||ATPase:1||RNA helicase:1||NUCLEOSIDE TRIPHOSPHATASE:1||ESCHERICHIACOLI:1||FELINE IMMUNODEFICIENCY VIRUS:1||TYPE1:1||ANIMALCELLS:1||GLYCOPROTEIN:1||VIRUS PROTEASE:1||POLYPROTEIN:1||RNAPOLYMERASE:1||SERUM:1||BCL2 RELATED GENES:1||HUMAN SPUMARETROVIRUS:1||DOWNREGULATION:1||ALLELES:1||ARGININERICH PEPTIDES:1||interleukin23:1||INTERFERONALPHA:1||RANKL:1||NITRICOXIDE SYNTHASE:1||VIRAL LOADS:1||SIVMAC:1||viral suppression:1||STIMULATING FACTOR GENE:1||MACROPHAGES:1||LATENT TUBERCULOSIS:1||immunization:1||Flt3L:1||LONGTERM CONTROL:1||VECTOR:1||TNFALPHA THERAPY:1||MESENCHYMAL STEMCELLS:1||malignant fibrous histiocytoma (MFH):1||EWINGSSARCOMA:1||MOUSE MODELS:1||RESISTANT:1||TUMORREGRESSION:1||STROMAL CELLS:1||Tuberculosis:1||TNF FAMILYMEMBER:1||M2e:1||Crossprotection:1||LYMPHOCYTEST:1||RECOGNITION:1||IFNgamma:1||TRANSCRIPTION:1||CpG oligodeoxynucleotides:1||Tcell priming:1||INTERLEUKIN2:1||cell cycle:1||proliferation:1||DAMAGE:1||DNA primerecombinant adenovirus boost:1||pharmacokinetics:1||REPAIR:1||CELLDEATH:1||OLIGODEOXYNUCLEOTIDES:1||BCELL:1||HUMAN HEPATOCELLULAR CARCINOMAS:1||NMR:1||MENGOVIRUS:1||transcriptional activation domain:1||BETA TCELLS:1||therapeutic vaccine:1||HELICASE DOMAIN:1||ISOLATE:1||FACTOR INTERLEUKIN12:1||ATP HYDROLYSIS:1||BOX:1||nonstructural protein:1||cytokine genes:1||COINOCULATION:1||LacZ:1||TYROSINEHYDROXYLASE:1||ADENOVIRUS VECTORS:1||PRODUCTS:1||REPORTER:1||PROGRAMMED CELLDEATH:1||NK CELL:1||PEGIFNalpha:1||I INTERFERON:1||nonhuman primates:1||CHRONIC HEPATITISB:1||Tcell response:1||chromosome instability:1||multigenic vaccine:1||MUCOSAL CHALLENGE:1||EXOGENOUS REINFECTION:1||MOLECULAR EPIDEMIOLOGY:1||Vaccination:1||IL7:1||IL15:1||CTL RESPONSE:1||SIMIANIMMUNODEFICIENCYVIRUS:1||REPLICATIONDEFECTIVE ADENOVIRUS:1||CYNOMOLGUS MONKEYS:1||VIRAL REPLICATION:1||SIV VACCINE:1||Mucosal immunity:1||collageninduced arthritis:1||interleukin27:1||TNBSINDUCED COLITIS:1||CD4(+) TCELLS:1||adenoviral transduction:1||ADIPOSETISSUE:1||TARGETEDDELIVERY:1||RADICAL PROSTATECTOMY:1||prophylactic model:1||tuberculosis:1||Flt3L:1||IL18:1||41BB (CD137):1||MHC class II:1||IL4:1||IMMUNOSTIMULATORY DENDRITIC CELLS:1||adjuvant:1||DNA VACCINES:1||PROGRAMMED DEATH1:1||CELLCYCLE:1||MEDIATED APOPTOSIS:1||CFLIP:1||RECEPTOR1:1||TRANSCRIPTIONAL REPRESSION:1||p38:1||ENDOPLASMICRETICULUM:1||PEPTIDE TRANSLOCATION:1||MATURATION:1||CPG OLIGODEOXYNUCLEOTIDES:1||SULFURDIOXIDE:1||GROWTH SUPPRESSION:1||ARREST:1||TH1 RESPONSES:1||AQUEOUSSOLUTION:1||CHRONIC NONA:1||PHOSPHATIDYLINOSITOL 3KINASE:1||OSTEOPROTEGERIN:1||MUTATIONAL ANALYSIS:1||TLYMPHOCYTE RESPONSE:1||influenza:1||INTRAMUSCULAR INJECTION:1||ENOLASE PROMOTER:1||PERIPHERAL NEURONS:1||E1:1||antiHCV:1||CARCINOGENESIS:1||CHLORAMPHENICOL ACETYLTRANSFERASE:1||ADENOVIRAL VECTOR:1||TRIMERIC TRAIL:1||BRAIN:1||PERMEABLE PEPTIDES:1||POWERFUL ADJUVANT:1||TOLERANCE:1||vaccine:1||GAG:1||HB110:1||CENTROSOME AMPLIFICATION:1||GENOMIC INSTABILITY:1||primeboost:1||PROTEIN VACCINE:1||mycobacterium tuberculosis:1||doublegene DNA vaccine:1||MODEL:1||Tcell responses:1||Vaccination and SIVmac239:1||CYTOTOXIC TLYMPHOCYTE:1||SOFTTISSUE SARCOMAS:1||PATHWAY:1||SYNOVIALFLUID:1||ANIMALMODELS:1||Inflammatory bowel disease (IBD):1||IL17A:1||CHRONIC HEPATITISC:1||TUMOR STROMA:1||BIOCHEMICALCHARACTERIZATION:1||Cavernous nerve:1||Matrixen:1||BIOLOGY:1||TUMORICIDAL ACTIVITY:1||ETANERCEPT:1||HYDROLYSIS:1||Matrigel:1||LUNG METASTASIS MODEL:1||JAPANESE ENCEPHALITISVIRUS:1||MONOCLONALANTIBODIES:1||NUCLEOPROTEIN:1||transgenic mouse:1||CENPE:1||aneuploid:1||lymphoma:1||INTERLEUKIN12 IL12:1||TISSUE DISTRIBUTION:1||BUBR1:1||ACTIVATED PROTEINKINASE:1||GAMMA EXPRESSION:1||INHIBITOR:1||NECROSISFACTORALPHA:1||TRANSDUCTION PATHWAY:1||p21(WAF1CIP1):1||SCAVENGER RECEPTORS:1||IMMUNE ACTIVATION:1||cyclin E:1||RETINOBLASTOMA PROTEIN:1||sindbis:1||CROSSTALK:1||NUCLEOTIDESEQUENCE:1||gene transfer:1||HERPESSIMPLEX VIRUS:1||POLYMERASE CHAINREACTION:1||CMYC:1||TAG